(Q82577799)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

cervical intraepithelial neoplasia

16 January 2020

main subject

1 reference

Oliver Brummer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bettina Hollwitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gerd Böhmer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Henning Kühnle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K Ulrich Petry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

17 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

517-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Clinical relevance of human papillomavirus testing in cytopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

The role of human papillomavirus testing in cervical screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

The role treatment for cervical intraepithelial neoplasia plays in the disappearance of human papilloma virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.020

10.1016/J.YGYNO.2006.01.020

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483642%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference